- ►annals.org SR Salpeter, GD Sanders, EE Salpeter, DK … - Annals of internal medicine, 1997 - Am Coll Physicians Background: Isoniazid chemoprophylaxis effectively prevents the development of
active infectious tuberculosis. Current guidelines recommend withholding this
prophylaxis for low-risk tuberculin reactors older than 35 years of age ... Cited by 80 - Related articles - BL Direct - All 6 versions
CB Schechter, DN Rose, MC Fahs, AL Silver - American journal of preventive medicine - ncbi.nlm.nih.gov Because there is no tuberculin screening schedule currently recommended for
adults, we used a Markov process in a cost-effectiveness analysis to determine
an optimal strategy. We simulated the prognosis of a cohort of black ... Cited by 28 - Related articles
- ►nih.gov [PDF] PS Millard, TC Wilcosky, SJ Reade- … - Western Journal of Medicine, 1996 - pubmedcentral.nih.gov To describe the clinical and demographic characteristics of fatal hepatitis due
to single-drug isoniazid preventive therapy for tuberculosis, we did a survey of
cases from state health departments, published case reports, and reports to ... Cited by 52 - Related articles - BL Direct - All 6 versions
JM Fitzgerald, A Gafni - The American review of respiratory disease, 1990 - ncbi.nlm.nih.gov The role of isoniazid prophylaxis in low-risk patients with positive Mantoux
skin tests has recently been questioned. In general, recent research has focused
on the risk/benefit ratio. We, therefore, decided to extend these data and ... Cited by 50 - Related articles
J Tsevat, WC Taylor, JB Wong, SG Pauker - The American review of respiratory disease, 1988 - ncbi.nlm.nih.gov The management of the adult tuberculin reactor who has no other risk factors for
the development of active tuberculosis is controversial. We performed a decision
analysis to address the issue of whether adults 20 to 80 yr of age should ... Cited by 42 - Related articles - All 2 versions
- ►nih.gov [PDF] SR Salpeter - Western Journal of Medicine, 1993 - pubmedcentral.nih.gov Isoniazid chemoprophylaxis has long been known to be a highly effective means of
preventing silent tuberculous infections from spreading to active disease. There
has been much controversy, however, about the risk it carries for fatal ... Cited by 55 - Related articles - BL Direct - All 7 versions
CM Nolan, SV Goldberg, SE Buskin - Jama, 1999 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 250 - Related articles - BL Direct - All 5 versions
JC Mohle-Boetani, B Miller, M Halpern, A … - JAMA: The Journal of the American Medical …, 1995 - jama.ama-assn.org.p.angrylapdog.com You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 71 - Related articles - Cached - BL Direct - All 6 versions
Z Taylor - The international journal of tuberculosis and lung …, 2000 - ncbi.nlm.nih.gov 1: Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S127-33. The cost-effectiveness
of screening for latent tuberculosis infection. Taylor Z. ... Cited by 15 - Related articles - BL Direct - All 3 versions
